In today's ACT Brief, we examine what patient-site relationships need most at DPHARM, how platform-based AI scales across ...

Benchmarking data showed sourcing approach did not reliably predict timeline, quality, or execution performance across 133 ...

As the life sciences industry continues to evolve, the ability to effectively manage and leverage preclinical CRO ...

In today's ACT Brief, we examine FDA's expedited pathway for first-in-human trials, why operating model design matters more ...

In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has ...

In a video interview prior to the 2026 DPHARM conference, Andrea Valente, CEO of uMotif, discussed the patient-site relationship, the role of technology in clinical trial delivery ...

A platform-based approach connects AI across workflows, data and governance, helping life sciences organizations move from isolated wins to real scale. AI adoption is moving quickly in life sciences, ...

Why clinical development’s next AI bottleneck is not the model, but the system around it.

In this Q&A, Patrick Mizer, chief technology officer at Ledger Run, discusses how payment reliability has become a ...

In today's ACT Brief, we examine what genuine patient voice requires beyond buzzwords, why AI's next bottleneck is system ...

True lab orchestration isn't about coordinating instruments, it's about connecting scientific intent, data, and decisions ...

In today's ACT Brief, we examine why seizure reduction misses what families want from epilepsy trials, how lab coordination ...